Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
Startups channel feed
George Church backs a startup solution to the massive gene therapy manufacturing bottleneck
5 years ago
Cell/Gene Tx
An Oxford spinout raises $44M as it looks to resurrect an old Roche antibody in pursuit of a rare disease
5 years ago
Financing
MPM, DCVC Bio back $53M round for a bold concept: Let patients make their own CAR-T in vivo
5 years ago
Financing
Cell/Gene Tx
Elevation Oncology bags $65M to push failed Merrimack drug through PhII
5 years ago
Financing
Here's a $200M China startup idea — if you can read beyond the big words
5 years ago
Financing
China
One of biotech's flashiest startups is finally getting some competition from a pioneer in a brand new field
5 years ago
A pharma R&D chief jumps to a budding new startup factory — and this time he’s found 'something completely different’
5 years ago
People
Chasing a 'master modulator' in the endocannabinoid system, biotech upstart promises to shake up neuropsychiatric treatments
5 years ago
Financing
Kira Pharmaceuticals emerges from stealth with $46M and new CEO to lead complement therapy mission
5 years ago
Financing
Decibel Therapeutics raises $82M as Laurence Reid looks to steer gene therapy pivot
5 years ago
Cell/Gene Tx
What do the top 10 biotech M&A deals of 2020 tell us? Premiums are in, bolt-ons rule and the ADC comeback is on
5 years ago
Deals
R&D
Flagship launches Senda Biosciences with $88M in backing, looking to pioneer the field of 'Intersystems Biology'
5 years ago
Financing
Arena's Amit Munshi spins out his neuro sub into a biotech startup, with $56M for the baptism
5 years ago
Financing
Can B cells break the boundaries of cell therapy? Longwood startup has $52M to prove a new engineering tech
5 years ago
Financing
Cell/Gene Tx
Pfizer scoops up an antibiotic in rare M&A deal, bagging a virtual startup operating on a shoestring budget
5 years ago
Deals
Bo Cumbo jumps from the top commercial post at Sarepta to the helm of a gene therapy startup with some influential backers, big plans and $107M
5 years ago
Financing
Cell/Gene Tx
A long-haul biotech with some impressive backers and big goals recruits a major league R&D exec to the helm. What’s next?
5 years ago
People
Novartis bet $6B on the idea — now Versant, venBio have $45M to birth a platform play for radiopharmaceuticals
5 years ago
Financing
Venrock takes the wrap off its first microbiome startup, armed with $50M, a CEO from 23andMe and two founders from Stanford
5 years ago
Financing
The latest Jennifer Doudna startup launches with a Biogen partnership and eyes on big targets few CRISPR companies have chased
5 years ago
People
The Endpoints 11: Here are some of the most promising startups in biotech. And Covid-19 isn't going to stop them
5 years ago
Special
A pharma exec gets $100M to chase a cancer-fighting idea uncovered in a 2017 Novartis study
5 years ago
Financing
With a $4M federal grant, Lumen jumps into the Covid-19 treatment race
5 years ago
Coronavirus
Flagship's next big technological bet? The cloud
5 years ago
Financing
First page
Previous page
51
52
53
54
55
56
57
Next page
Last page